Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price purchased 5,000,000 shares of the stock in a transaction dated Monday, March 31st. The stock was bought at an average cost of A$0.01 ($0.01) per share, with a total value of A$60,000.00 ($36,363.64).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Articles
- Five stocks we like better than Percheron Therapeutics
- What is the Nikkei 225 index?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Profit From Value Investing
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
